TNGX   $8.419  1.68% Market Closed After Close 8.37 -0.58%

Tango Therapeutics Inc
Total Cash 322.11M
totalCashPerShare 3.006
EBITDA -129.96M
Total Debt 37.84M
quickRatio 7.343
currentRatio 7.486
Total Revenue 42.51M
debtToEquity 15.277
Revenue/Share 0.406
ROA -0.21761999
ROE -0.5058
grossProfits
freeCashflow -63.78M
operatingCashflow -120.07M
earningsGrowth
revenueGrowth 0.361
grossMargins -2.18067
ebitdaMargins 0.0
operatingMargins -1.48689
profitMargins -2.74038
enterpriseValue 840.74M
forwardPE -6.712329
floatShares 49.31M
sharesOutstanding 107.14M
sharesShort 10.21M
sharesShortPriorMonth 9.12M
dateShortInterest
sharesPercentSharesOut 0.10%
heldPercentInsiders 0.13%
heldPercentInstitutions 0.90%
Short Ratio help_outline 16.85%
shortPercentOfFloat 0.18%
impliedSharesOutstanding
bookValue 2.314
Price To Book help_outline 4.24
earningsQuarterlyGrowth
netIncomeToCommon -116.49M
trailingEps -1.11%
forwardEps -1.46%
enterpriseToEbitda -6.47
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.37 3Q 2024
institutionsCount 175
lastUpdated Sept. 16, 2024, 8:39 p.m.